The steep weight loss and significant cardiovascular and metabolic benefits associated with drugs like semaglutide and tirzepatide underlie their rapid rise in popularity
If night sweats occur during treatment, other causes should be thoroughly investigated
Rybelsus must be taken on an empty stomach with only a small amount of water and you must wait before eating
The global GLP-1 market was valued at $52.82 billion in 2025 and is projected to reach $133.92 billion by 2034, growing at 10.9 percent annually
Formichi C, Baronti W, de Gennaro G, Cerrai Ceroni M, Nigi L, Rizzo L, et al
Liraglutide weight loss clinical trials Semaglutide is another GLP-1 product developed by Novo Nordisk with a better weight loss effect than liraglutide